Bulgaria's FSC Asks Sopharma Trading for More Info on Cap Hike Prospectus

Bulgaria's FSC Asks Sopharma Trading for More Info on Cap Hike Prospectus

Bulgaria's Financial Supervision Commission said that it has asked local drug trader Sopharma Trading to provide further information and documents regarding its request for approval of a capital increase prospectus. The financial regulator did not disclose further details in its statement, published on Thursday. Last month, Sopharma Trading said that it will seek to raise up to 9.4 million levs ($5.3 million/4.8 million euro) via a new share issue. Sopharma Trading plans to offer 1,371,042 for subscription at a price of 6.85 levs apiece. The company's capital currently amounts to some 32.9 million levs, divided into the same number of shares. As at 9:05 CET on Friday, Sopharma Trading shares traded at 3.28 levs, unchanged from their previous closing price on the Bulgarian Stock Exchange. Sopharma Trading is a unit of Bulgarian drug maker Sopharma .

Previous Next
Test Caption
Test Description goes like this
Cookies Preferences
Choose Type of Cookies You Accept Using

These cookies are required for the website to run and cannot be switched off. Such cookie are only set in response to actions made by you such as language, currency, login session, privacy preferences. You can set your browser to block these cookies but our site may not work then.

These cookies allow us to measure visitors traffic and see traffic sources by collecting information in data sets. They also help us understand which products and actions are more popular than others.

These cookies are usually set by our marketing and advertising partners. They may be used by them to build a profile of your interest and later show you relevant ads. If you do not allow these cookies you will not experience targeted ads for your interests.